Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its access have become key issues for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its costly nature presents a significant obstacle to many. Negoti